ReviewJournal of market access & health policy2019
Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma.
Xavier Armoiry et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.